ABSTRACT Objective To evaluate the cost-effectiveness of the addition of chemotherapy or abiraterone to androgen deprivation. Methods We developed an analytical model to determine the cost-effectiveness of the addition of docetaxel or abiraterone versus androgen deprivation therapy alone. Direct and indirect costs were included in the model. https://www.itsmajorlook.com/great-deal-Chicago-Cubs-Earrings-Round-Design-p21310-limited-grab/